Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

HBV

Last Updated: August 1, 2019; Last Reviewed: August 1, 2019

Hepatitis B Virus Infection
Member Financial Disclosure
Company Relationship
Bhattacharya, Debika University of California, Los Angeles AbbVie Research Support
National Institutes of Health Research Support
Harris, Aaron Centers for Disease Control and Prevention
None N/A
Hawkins, Claudia Northwestern University
National Institutes of Health Research Support
Peters, Marion University of California, San Francisco Abbott Advisory Board
Antios Advisory Board
Thio, Chole* Johns Hopkins University
Sanofi U.S. Research Support

* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines